| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thrombectomy | 79 | 2023 | 238 | 17.760 |
Why?
|
| Endovascular Procedures | 66 | 2023 | 366 | 15.200 |
Why?
|
| Intracranial Aneurysm | 42 | 2022 | 87 | 15.020 |
Why?
|
| Embolization, Therapeutic | 40 | 2022 | 150 | 13.360 |
Why?
|
| Stroke | 79 | 2023 | 2163 | 9.900 |
Why?
|
| Brain Ischemia | 46 | 2023 | 665 | 9.290 |
Why?
|
| Stents | 45 | 2022 | 657 | 6.770 |
Why?
|
| Neurosurgery | 14 | 2022 | 42 | 5.500 |
Why?
|
| Treatment Outcome | 111 | 2023 | 7029 | 4.450 |
Why?
|
| Neurosurgeons | 12 | 2022 | 22 | 4.140 |
Why?
|
| Neurosurgical Procedures | 13 | 2022 | 98 | 3.870 |
Why?
|
| Cerebral Angiography | 30 | 2021 | 151 | 3.810 |
Why?
|
| Retrospective Studies | 95 | 2023 | 7277 | 3.500 |
Why?
|
| Aneurysm, Ruptured | 13 | 2022 | 40 | 3.410 |
Why?
|
| Internship and Residency | 11 | 2019 | 596 | 3.080 |
Why?
|
| Catheters | 10 | 2022 | 39 | 3.080 |
Why?
|
| Aged | 98 | 2022 | 14862 | 3.010 |
Why?
|
| Humans | 210 | 2023 | 68618 | 2.870 |
Why?
|
| Cerebral Hemorrhage | 14 | 2021 | 198 | 2.660 |
Why?
|
| Hematoma, Subdural, Chronic | 5 | 2022 | 9 | 2.660 |
Why?
|
| Middle Aged | 112 | 2022 | 21147 | 2.640 |
Why?
|
| Polyvinyls | 6 | 2014 | 24 | 2.600 |
Why?
|
| Prospective Studies | 39 | 2022 | 3705 | 2.590 |
Why?
|
| Male | 134 | 2022 | 37321 | 2.520 |
Why?
|
| Balloon Occlusion | 7 | 2014 | 22 | 2.510 |
Why?
|
| Blood Pressure | 14 | 2021 | 1451 | 2.420 |
Why?
|
| Radial Artery | 5 | 2021 | 43 | 2.400 |
Why?
|
| Aged, 80 and over | 46 | 2022 | 4848 | 2.320 |
Why?
|
| Female | 121 | 2022 | 38074 | 2.240 |
Why?
|
| Registries | 18 | 2022 | 733 | 2.080 |
Why?
|
| Central Nervous System Vascular Malformations | 5 | 2013 | 10 | 1.990 |
Why?
|
| Burnout, Professional | 7 | 2022 | 64 | 1.930 |
Why?
|
| Coronavirus Infections | 6 | 2020 | 143 | 1.740 |
Why?
|
| Pneumonia, Viral | 6 | 2020 | 154 | 1.730 |
Why?
|
| Pandemics | 8 | 2021 | 352 | 1.730 |
Why?
|
| Dimethyl Sulfoxide | 4 | 2014 | 30 | 1.670 |
Why?
|
| Postoperative Complications | 13 | 2021 | 1615 | 1.620 |
Why?
|
| Carotid Artery Diseases | 5 | 2021 | 83 | 1.600 |
Why?
|
| Reperfusion | 9 | 2020 | 78 | 1.600 |
Why?
|
| Cerebral Arteries | 4 | 2019 | 50 | 1.590 |
Why?
|
| Subarachnoid Hemorrhage | 12 | 2020 | 61 | 1.540 |
Why?
|
| Femoral Artery | 3 | 2020 | 139 | 1.530 |
Why?
|
| Health Promotion | 5 | 2019 | 407 | 1.480 |
Why?
|
| Patient Selection | 4 | 2019 | 592 | 1.470 |
Why?
|
| Tissue Plasminogen Activator | 7 | 2021 | 296 | 1.460 |
Why?
|
| Arterial Occlusive Diseases | 6 | 2021 | 134 | 1.410 |
Why?
|
| Carotid Artery, Internal | 9 | 2021 | 85 | 1.370 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2020 | 182 | 1.340 |
Why?
|
| Infarction, Middle Cerebral Artery | 6 | 2020 | 105 | 1.330 |
Why?
|
| Meningeal Arteries | 5 | 2022 | 9 | 1.330 |
Why?
|
| Adult | 50 | 2022 | 21403 | 1.280 |
Why?
|
| Fibrinolytic Agents | 10 | 2021 | 377 | 1.190 |
Why?
|
| Thrombolytic Therapy | 13 | 2021 | 233 | 1.170 |
Why?
|
| Superior Sagittal Sinus | 2 | 2021 | 8 | 1.140 |
Why?
|
| Mechanical Thrombolysis | 5 | 2021 | 29 | 1.100 |
Why?
|
| Intracranial Thrombosis | 2 | 2018 | 14 | 1.100 |
Why?
|
| Basilar Artery | 6 | 2021 | 38 | 1.060 |
Why?
|
| Severity of Illness Index | 8 | 2019 | 1851 | 1.030 |
Why?
|
| Thromboembolism | 3 | 2021 | 91 | 1.030 |
Why?
|
| Cerebral Revascularization | 5 | 2020 | 45 | 1.010 |
Why?
|
| Betacoronavirus | 4 | 2020 | 116 | 1.000 |
Why?
|
| Databases, Factual | 11 | 2021 | 622 | 1.000 |
Why?
|
| Time-to-Treatment | 3 | 2020 | 117 | 0.990 |
Why?
|
| Anterior Cerebral Artery | 2 | 2021 | 5 | 0.980 |
Why?
|
| Minimally Invasive Surgical Procedures | 4 | 2020 | 85 | 0.970 |
Why?
|
| Colloid Cysts | 2 | 2014 | 3 | 0.970 |
Why?
|
| Ventriculostomy | 2 | 2014 | 7 | 0.970 |
Why?
|
| Mindfulness | 2 | 2022 | 41 | 0.960 |
Why?
|
| Thrombosis | 3 | 2022 | 218 | 0.940 |
Why?
|
| Tantalum | 2 | 2014 | 6 | 0.940 |
Why?
|
| Hypothalamus | 2 | 2014 | 78 | 0.930 |
Why?
|
| Catheterization | 4 | 2019 | 209 | 0.900 |
Why?
|
| Cerebral Arterial Diseases | 2 | 2021 | 28 | 0.890 |
Why?
|
| Intracranial Hypertension | 3 | 2021 | 53 | 0.880 |
Why?
|
| Carotid Artery, Common | 2 | 2014 | 25 | 0.870 |
Why?
|
| Radiography | 13 | 2014 | 572 | 0.840 |
Why?
|
| Intracranial Hemorrhages | 8 | 2021 | 80 | 0.750 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2020 | 373 | 0.740 |
Why?
|
| Brain Infarction | 2 | 2017 | 54 | 0.730 |
Why?
|
| Follow-Up Studies | 14 | 2021 | 3259 | 0.730 |
Why?
|
| Curriculum | 2 | 2015 | 575 | 0.730 |
Why?
|
| Aneurysm, Infected | 2 | 2018 | 16 | 0.730 |
Why?
|
| Angioplasty, Balloon | 4 | 2021 | 110 | 0.730 |
Why?
|
| Clinical Competence | 3 | 2015 | 657 | 0.710 |
Why?
|
| Economics, Hospital | 1 | 2020 | 15 | 0.710 |
Why?
|
| Platelet Function Tests | 1 | 2020 | 10 | 0.710 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 18 | 0.710 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 27 | 0.710 |
Why?
|
| Intracranial Arteriosclerosis | 7 | 2021 | 134 | 0.700 |
Why?
|
| Computer Simulation | 2 | 2015 | 706 | 0.700 |
Why?
|
| Paracentesis | 1 | 2020 | 25 | 0.700 |
Why?
|
| Infusion Pumps | 1 | 2019 | 39 | 0.690 |
Why?
|
| Benchmarking | 1 | 2020 | 91 | 0.680 |
Why?
|
| Intraoperative Complications | 1 | 2020 | 129 | 0.670 |
Why?
|
| Intergenerational Relations | 1 | 2018 | 8 | 0.650 |
Why?
|
| Prosthesis Design | 1 | 2020 | 301 | 0.650 |
Why?
|
| Psychology, Sports | 1 | 2018 | 1 | 0.640 |
Why?
|
| Optimism | 1 | 2018 | 1 | 0.640 |
Why?
|
| Physicians | 5 | 2020 | 324 | 0.640 |
Why?
|
| Hypertension | 4 | 2020 | 1535 | 0.630 |
Why?
|
| Spouses | 1 | 2019 | 51 | 0.630 |
Why?
|
| Imagination | 1 | 2018 | 38 | 0.630 |
Why?
|
| Physical Endurance | 1 | 2018 | 38 | 0.630 |
Why?
|
| Athletes | 1 | 2018 | 40 | 0.620 |
Why?
|
| Personality | 1 | 2018 | 66 | 0.620 |
Why?
|
| Brain | 7 | 2011 | 2176 | 0.620 |
Why?
|
| Third Ventricle | 2 | 2014 | 4 | 0.600 |
Why?
|
| Brain Injuries | 3 | 2010 | 268 | 0.580 |
Why?
|
| Machine Learning | 1 | 2019 | 170 | 0.580 |
Why?
|
| Cohort Studies | 10 | 2022 | 2358 | 0.580 |
Why?
|
| Neurology | 2 | 2015 | 43 | 0.580 |
Why?
|
| Psychomotor Performance | 1 | 2018 | 213 | 0.560 |
Why?
|
| Oxygen | 5 | 2010 | 386 | 0.560 |
Why?
|
| Physical Education and Training | 1 | 2016 | 24 | 0.550 |
Why?
|
| Transverse Sinuses | 2 | 2020 | 3 | 0.550 |
Why?
|
| Healthy Lifestyle | 1 | 2016 | 21 | 0.550 |
Why?
|
| Seizures | 1 | 2018 | 279 | 0.550 |
Why?
|
| Hematoma | 2 | 2020 | 47 | 0.530 |
Why?
|
| Angiography | 5 | 2021 | 194 | 0.530 |
Why?
|
| Head | 2 | 2013 | 59 | 0.530 |
Why?
|
| Tremor | 1 | 2015 | 16 | 0.530 |
Why?
|
| Brain Concussion | 2 | 2018 | 27 | 0.530 |
Why?
|
| Monitoring, Physiologic | 4 | 2011 | 219 | 0.520 |
Why?
|
| Microsurgery | 1 | 2015 | 46 | 0.510 |
Why?
|
| Neuroendoscopy | 1 | 2015 | 4 | 0.510 |
Why?
|
| Therapeutic Occlusion | 1 | 2014 | 2 | 0.500 |
Why?
|
| Posterior Cerebral Artery | 1 | 2014 | 1 | 0.490 |
Why?
|
| Pilot Projects | 5 | 2022 | 1342 | 0.480 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2014 | 15 | 0.480 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2022 | 2324 | 0.480 |
Why?
|
| Functional Laterality | 1 | 2015 | 240 | 0.480 |
Why?
|
| Drug-Eluting Stents | 1 | 2015 | 51 | 0.480 |
Why?
|
| Recovery of Function | 8 | 2021 | 506 | 0.470 |
Why?
|
| Endarterectomy, Carotid | 1 | 2015 | 110 | 0.470 |
Why?
|
| Basal Ganglia Cerebrovascular Disease | 1 | 2014 | 3 | 0.470 |
Why?
|
| Endoscopy | 2 | 2014 | 464 | 0.460 |
Why?
|
| Simulation Training | 1 | 2014 | 49 | 0.460 |
Why?
|
| Balloon Embolectomy | 1 | 2013 | 1 | 0.460 |
Why?
|
| Health Status | 1 | 2016 | 429 | 0.450 |
Why?
|
| Hospitals | 3 | 2019 | 265 | 0.450 |
Why?
|
| Anesthesia, General | 4 | 2020 | 86 | 0.450 |
Why?
|
| Surveys and Questionnaires | 7 | 2022 | 2800 | 0.450 |
Why?
|
| Time Factors | 11 | 2021 | 4655 | 0.440 |
Why?
|
| Neck | 1 | 2013 | 62 | 0.440 |
Why?
|
| Cranial Fossa, Anterior | 1 | 2013 | 8 | 0.440 |
Why?
|
| Quality of Life | 2 | 2019 | 1515 | 0.440 |
Why?
|
| Angioplasty | 2 | 2010 | 118 | 0.420 |
Why?
|
| Aneurysm, False | 1 | 2013 | 60 | 0.420 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 1465 | 0.410 |
Why?
|
| Venous Cutdown | 1 | 2011 | 1 | 0.400 |
Why?
|
| Recurrence | 7 | 2021 | 948 | 0.400 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2017 | 181 | 0.400 |
Why?
|
| Tertiary Care Centers | 1 | 2012 | 67 | 0.400 |
Why?
|
| Device Removal | 2 | 2014 | 100 | 0.390 |
Why?
|
| Interdisciplinary Studies | 1 | 2011 | 6 | 0.390 |
Why?
|
| Middle Cerebral Artery | 3 | 2019 | 57 | 0.390 |
Why?
|
| Wounds, Penetrating | 1 | 2011 | 45 | 0.380 |
Why?
|
| Craniocerebral Trauma | 4 | 2018 | 50 | 0.380 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2010 | 7 | 0.370 |
Why?
|
| Indocyanine Green | 1 | 2010 | 4 | 0.370 |
Why?
|
| Public Opinion | 1 | 2011 | 32 | 0.370 |
Why?
|
| Embolic Protection Devices | 1 | 2010 | 12 | 0.370 |
Why?
|
| Surgical Instruments | 1 | 2011 | 44 | 0.370 |
Why?
|
| Blood Pressure Determination | 3 | 2020 | 152 | 0.370 |
Why?
|
| Young Adult | 10 | 2021 | 5717 | 0.360 |
Why?
|
| Cattle | 1 | 2011 | 475 | 0.360 |
Why?
|
| Surgery Department, Hospital | 1 | 2010 | 19 | 0.360 |
Why?
|
| Fellowships and Scholarships | 1 | 2011 | 127 | 0.360 |
Why?
|
| Athletic Injuries | 1 | 2011 | 73 | 0.360 |
Why?
|
| Self Expandable Metallic Stents | 2 | 2020 | 14 | 0.350 |
Why?
|
| Combined Modality Therapy | 7 | 2019 | 951 | 0.350 |
Why?
|
| Referral and Consultation | 4 | 2020 | 383 | 0.350 |
Why?
|
| Angiography, Digital Subtraction | 4 | 2018 | 63 | 0.340 |
Why?
|
| Iatrogenic Disease | 2 | 2021 | 36 | 0.330 |
Why?
|
| Job Satisfaction | 2 | 2020 | 62 | 0.330 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2011 | 186 | 0.330 |
Why?
|
| Vascular Surgical Procedures | 1 | 2010 | 168 | 0.330 |
Why?
|
| Carotid Arteries | 2 | 2019 | 110 | 0.320 |
Why?
|
| Atrial Fibrillation | 2 | 2021 | 249 | 0.320 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 281 | 0.310 |
Why?
|
| Mental Health | 3 | 2019 | 278 | 0.300 |
Why?
|
| Risk Factors | 12 | 2023 | 5731 | 0.300 |
Why?
|
| Scalp | 1 | 2008 | 47 | 0.300 |
Why?
|
| Fever | 1 | 2008 | 96 | 0.290 |
Why?
|
| Prosthesis Implantation | 1 | 2008 | 83 | 0.290 |
Why?
|
| Surgical Flaps | 1 | 2008 | 120 | 0.290 |
Why?
|
| Oxygen Consumption | 1 | 2008 | 258 | 0.290 |
Why?
|
| Cranial Sinuses | 2 | 2017 | 11 | 0.280 |
Why?
|
| Incidence | 4 | 2019 | 1603 | 0.280 |
Why?
|
| Odds Ratio | 2 | 2018 | 880 | 0.270 |
Why?
|
| Jugular Veins | 3 | 2021 | 37 | 0.270 |
Why?
|
| Attitude of Health Personnel | 2 | 2020 | 442 | 0.270 |
Why?
|
| Carotid Stenosis | 2 | 2019 | 163 | 0.260 |
Why?
|
| Vascular Access Devices | 3 | 2017 | 21 | 0.260 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2018 | 239 | 0.240 |
Why?
|
| United States | 8 | 2023 | 7367 | 0.240 |
Why?
|
| Computed Tomography Angiography | 2 | 2019 | 424 | 0.230 |
Why?
|
| Internationality | 2 | 2021 | 74 | 0.230 |
Why?
|
| Treatment Failure | 3 | 2015 | 216 | 0.220 |
Why?
|
| Ohio | 4 | 2011 | 64 | 0.220 |
Why?
|
| Drug Combinations | 2 | 2014 | 304 | 0.220 |
Why?
|
| Acute Disease | 3 | 2020 | 658 | 0.220 |
Why?
|
| Patient Admission | 2 | 2020 | 99 | 0.220 |
Why?
|
| Workflow | 2 | 2020 | 100 | 0.210 |
Why?
|
| Mortality | 2 | 2020 | 163 | 0.210 |
Why?
|
| Risk Assessment | 4 | 2021 | 2007 | 0.200 |
Why?
|
| Vasospasm, Intracranial | 3 | 2013 | 16 | 0.200 |
Why?
|
| Carotid Artery, Internal, Dissection | 2 | 2021 | 9 | 0.200 |
Why?
|
| Hemorrhage | 2 | 2023 | 328 | 0.200 |
Why?
|
| Patient Transfer | 2 | 2020 | 86 | 0.200 |
Why?
|
| Costs and Cost Analysis | 2 | 2020 | 193 | 0.200 |
Why?
|
| Suction | 3 | 2017 | 33 | 0.190 |
Why?
|
| Intraoperative Care | 2 | 2020 | 91 | 0.190 |
Why?
|
| Disease Management | 3 | 2019 | 248 | 0.190 |
Why?
|
| Swine | 2 | 2014 | 672 | 0.190 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2021 | 20 | 0.190 |
Why?
|
| Intracranial Pressure | 4 | 2010 | 58 | 0.190 |
Why?
|
| Cerebrovascular Circulation | 2 | 2020 | 296 | 0.190 |
Why?
|
| After-Hours Care | 1 | 2020 | 17 | 0.180 |
Why?
|
| Aneurysm | 1 | 2020 | 53 | 0.180 |
Why?
|
| Neovascularization, Pathologic | 1 | 2021 | 183 | 0.180 |
Why?
|
| Learning Curve | 1 | 2020 | 20 | 0.180 |
Why?
|
| Central Venous Pressure | 1 | 2020 | 11 | 0.180 |
Why?
|
| Delayed Diagnosis | 1 | 2020 | 39 | 0.180 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 60 | 0.180 |
Why?
|
| Hypotension | 1 | 2020 | 74 | 0.180 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 95 | 0.180 |
Why?
|
| Upper Extremity | 1 | 2021 | 112 | 0.170 |
Why?
|
| Goals | 1 | 2020 | 65 | 0.170 |
Why?
|
| Physician's Role | 1 | 2020 | 116 | 0.170 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 99 | 0.170 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2019 | 64 | 0.170 |
Why?
|
| Ischemic Attack, Transient | 2 | 2018 | 167 | 0.170 |
Why?
|
| South Carolina | 4 | 2020 | 2752 | 0.170 |
Why?
|
| History, 21st Century | 2 | 2010 | 127 | 0.170 |
Why?
|
| Expectorants | 1 | 2018 | 5 | 0.160 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2018 | 27 | 0.160 |
Why?
|
| Bombs | 1 | 2018 | 2 | 0.160 |
Why?
|
| Prognosis | 3 | 2020 | 2093 | 0.160 |
Why?
|
| Sleep | 2 | 2018 | 263 | 0.160 |
Why?
|
| India | 1 | 2018 | 41 | 0.160 |
Why?
|
| Complement System Proteins | 1 | 2020 | 135 | 0.160 |
Why?
|
| History, 20th Century | 2 | 2010 | 248 | 0.160 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 159 | 0.160 |
Why?
|
| Professionalism | 1 | 2018 | 28 | 0.160 |
Why?
|
| Critical Care | 3 | 2011 | 263 | 0.160 |
Why?
|
| Anticoagulants | 2 | 2019 | 356 | 0.160 |
Why?
|
| Heparin | 1 | 2019 | 205 | 0.160 |
Why?
|
| Self-Assessment | 1 | 2018 | 69 | 0.160 |
Why?
|
| Efficiency | 1 | 2018 | 49 | 0.160 |
Why?
|
| Electroencephalography | 2 | 2018 | 418 | 0.150 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 182 | 0.150 |
Why?
|
| Self Concept | 1 | 2018 | 132 | 0.150 |
Why?
|
| Personality Inventory | 1 | 2018 | 197 | 0.150 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2017 | 2 | 0.150 |
Why?
|
| Synapses | 1 | 2020 | 222 | 0.150 |
Why?
|
| Neuronavigation | 1 | 2017 | 8 | 0.150 |
Why?
|
| Diet | 2 | 2018 | 514 | 0.150 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 807 | 0.150 |
Why?
|
| Equipment Design | 3 | 2015 | 500 | 0.150 |
Why?
|
| Lateral Medullary Syndrome | 1 | 2017 | 2 | 0.150 |
Why?
|
| Retreatment | 2 | 2017 | 59 | 0.150 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2017 | 6 | 0.150 |
Why?
|
| Operative Time | 1 | 2017 | 45 | 0.140 |
Why?
|
| Radiologists | 1 | 2017 | 35 | 0.140 |
Why?
|
| Workload | 1 | 2018 | 103 | 0.140 |
Why?
|
| Health Personnel | 1 | 2020 | 286 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 176 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 378 | 0.140 |
Why?
|
| Logistic Models | 2 | 2019 | 1420 | 0.140 |
Why?
|
| Massachusetts | 1 | 2016 | 28 | 0.140 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2016 | 17 | 0.140 |
Why?
|
| Boston | 1 | 2016 | 35 | 0.140 |
Why?
|
| Occupational Health Services | 1 | 2016 | 14 | 0.140 |
Why?
|
| Wakefulness | 1 | 2016 | 75 | 0.140 |
Why?
|
| Arteries | 2 | 2021 | 108 | 0.130 |
Why?
|
| Feasibility Studies | 2 | 2016 | 652 | 0.130 |
Why?
|
| Survival Rate | 1 | 2019 | 1056 | 0.130 |
Why?
|
| Intersectoral Collaboration | 1 | 2016 | 27 | 0.130 |
Why?
|
| Europe | 3 | 2021 | 196 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 468 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 445 | 0.130 |
Why?
|
| Single-Blind Method | 1 | 2016 | 249 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 1046 | 0.130 |
Why?
|
| Manometry | 1 | 2016 | 276 | 0.130 |
Why?
|
| California | 1 | 2015 | 99 | 0.130 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 320 | 0.130 |
Why?
|
| Motor Skills | 1 | 2015 | 88 | 0.130 |
Why?
|
| Physical Fitness | 1 | 2016 | 117 | 0.120 |
Why?
|
| Sepsis | 1 | 2018 | 233 | 0.120 |
Why?
|
| Alloys | 1 | 2015 | 66 | 0.120 |
Why?
|
| Reoperation | 2 | 2018 | 467 | 0.120 |
Why?
|
| Animals | 6 | 2020 | 20881 | 0.120 |
Why?
|
| Cognition | 1 | 2018 | 513 | 0.120 |
Why?
|
| Endocarditis | 1 | 2014 | 14 | 0.120 |
Why?
|
| Growth Hormone-Secreting Pituitary Adenoma | 1 | 2014 | 3 | 0.120 |
Why?
|
| Acromegaly | 1 | 2014 | 5 | 0.120 |
Why?
|
| Growth Hormone | 1 | 2014 | 51 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 711 | 0.120 |
Why?
|
| Cerebellopontine Angle | 1 | 2013 | 1 | 0.110 |
Why?
|
| Pituitary Neoplasms | 1 | 2014 | 52 | 0.110 |
Why?
|
| Dura Mater | 1 | 2013 | 23 | 0.110 |
Why?
|
| Models, Animal | 1 | 2014 | 252 | 0.110 |
Why?
|
| Fatal Outcome | 2 | 2011 | 164 | 0.110 |
Why?
|
| Arteriovenous Fistula | 1 | 2013 | 25 | 0.110 |
Why?
|
| Fluoroscopy | 1 | 2014 | 152 | 0.110 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 438 | 0.110 |
Why?
|
| Guideline Adherence | 1 | 2015 | 287 | 0.110 |
Why?
|
| Blister | 1 | 2013 | 16 | 0.110 |
Why?
|
| Central Venous Catheters | 1 | 2013 | 19 | 0.110 |
Why?
|
| Adenoma | 1 | 2014 | 132 | 0.110 |
Why?
|
| Equipment Failure | 1 | 2012 | 112 | 0.100 |
Why?
|
| Aminocaproic Acid | 1 | 2012 | 12 | 0.100 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 551 | 0.100 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2012 | 7 | 0.100 |
Why?
|
| Telemedicine | 1 | 2020 | 700 | 0.100 |
Why?
|
| Soccer | 1 | 2012 | 13 | 0.100 |
Why?
|
| Adolescent | 7 | 2021 | 8912 | 0.100 |
Why?
|
| Prostheses and Implants | 1 | 2013 | 159 | 0.100 |
Why?
|
| Trauma, Nervous System | 1 | 2011 | 6 | 0.100 |
Why?
|
| Latin America | 1 | 2011 | 19 | 0.100 |
Why?
|
| Spain | 1 | 2011 | 34 | 0.100 |
Why?
|
| Antifibrinolytic Agents | 1 | 2012 | 52 | 0.100 |
Why?
|
| Neck Injuries | 1 | 2011 | 17 | 0.100 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 1506 | 0.100 |
Why?
|
| Lumbosacral Region | 1 | 2011 | 18 | 0.100 |
Why?
|
| Pan troglodytes | 1 | 2011 | 6 | 0.100 |
Why?
|
| Nevus | 1 | 2011 | 17 | 0.100 |
Why?
|
| Peripheral Nerves | 1 | 2011 | 22 | 0.090 |
Why?
|
| Arteriovenous Malformations | 1 | 2011 | 34 | 0.090 |
Why?
|
| Corpus Callosum | 1 | 2011 | 29 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1140 | 0.090 |
Why?
|
| Vasodilator Agents | 2 | 2016 | 138 | 0.090 |
Why?
|
| Multiple Trauma | 1 | 2011 | 50 | 0.090 |
Why?
|
| Blood Coagulation Disorders | 1 | 2011 | 45 | 0.090 |
Why?
|
| Intraoperative Period | 1 | 2010 | 62 | 0.090 |
Why?
|
| Hypoxia, Brain | 1 | 2010 | 16 | 0.090 |
Why?
|
| Body Temperature | 2 | 2008 | 116 | 0.090 |
Why?
|
| Central Nervous System | 1 | 2011 | 107 | 0.090 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2011 | 77 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 508 | 0.090 |
Why?
|
| Propensity Score | 2 | 2021 | 117 | 0.090 |
Why?
|
| Exercise | 1 | 2016 | 658 | 0.090 |
Why?
|
| Pharynx | 1 | 2010 | 89 | 0.090 |
Why?
|
| Child | 5 | 2021 | 6405 | 0.090 |
Why?
|
| Program Development | 1 | 2011 | 240 | 0.090 |
Why?
|
| Comorbidity | 2 | 2011 | 1426 | 0.090 |
Why?
|
| Postoperative Care | 1 | 2010 | 163 | 0.090 |
Why?
|
| Spinal Cord | 1 | 2010 | 244 | 0.080 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2011 | 123 | 0.080 |
Why?
|
| Medical Illustration | 1 | 2009 | 4 | 0.080 |
Why?
|
| Hospital Mortality | 2 | 2021 | 384 | 0.080 |
Why?
|
| Administration, Intravenous | 2 | 2020 | 89 | 0.080 |
Why?
|
| Heart-Assist Devices | 1 | 2011 | 221 | 0.080 |
Why?
|
| Conscious Sedation | 2 | 2020 | 61 | 0.080 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2007 | 4 | 0.070 |
Why?
|
| Head Injuries, Closed | 1 | 2006 | 9 | 0.070 |
Why?
|
| Skin Neoplasms | 1 | 2011 | 375 | 0.070 |
Why?
|
| Papaverine | 1 | 2006 | 10 | 0.070 |
Why?
|
| Prevalence | 2 | 2021 | 1619 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2011 | 2223 | 0.060 |
Why?
|
| Hospitalization | 2 | 2021 | 978 | 0.060 |
Why?
|
| Cytidine Triphosphate | 1 | 2022 | 3 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2023 | 109 | 0.050 |
Why?
|
| Perfusion | 1 | 2022 | 131 | 0.050 |
Why?
|
| Morals | 1 | 2022 | 27 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 2077 | 0.050 |
Why?
|
| Asia | 1 | 2021 | 59 | 0.050 |
Why?
|
| France | 1 | 2021 | 26 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 2 | 2014 | 504 | 0.050 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2021 | 17 | 0.050 |
Why?
|
| North America | 1 | 2021 | 112 | 0.050 |
Why?
|
| Craniotomy | 1 | 2020 | 33 | 0.040 |
Why?
|
| Independent Living | 1 | 2020 | 44 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2020 | 39 | 0.040 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 38 | 0.040 |
Why?
|
| Pseudotumor Cerebri | 1 | 2020 | 43 | 0.040 |
Why?
|
| Patient Safety | 1 | 2021 | 202 | 0.040 |
Why?
|
| Equivalence Trials as Topic | 1 | 2019 | 7 | 0.040 |
Why?
|
| Armed Conflicts | 1 | 2018 | 3 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2014 | 1553 | 0.040 |
Why?
|
| Terrorism | 1 | 2018 | 21 | 0.040 |
Why?
|
| Bias | 1 | 2019 | 148 | 0.040 |
Why?
|
| Lebanon | 1 | 2018 | 67 | 0.040 |
Why?
|
| Linear Models | 1 | 2020 | 521 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2019 | 123 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2018 | 236 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2020 | 714 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2020 | 705 | 0.040 |
Why?
|
| Observer Variation | 1 | 2017 | 330 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2020 | 867 | 0.030 |
Why?
|
| Verapamil | 1 | 2016 | 30 | 0.030 |
Why?
|
| Glasgow Coma Scale | 2 | 2006 | 65 | 0.030 |
Why?
|
| Military Personnel | 1 | 2018 | 221 | 0.030 |
Why?
|
| Stroke Rehabilitation | 1 | 2020 | 335 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 931 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2017 | 236 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2016 | 103 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 772 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2016 | 157 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2019 | 1738 | 0.030 |
Why?
|
| Smoking | 1 | 2023 | 1452 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2018 | 1330 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2014 | 86 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 2791 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 110 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2015 | 344 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 3187 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1864 | 0.030 |
Why?
|
| Head Movements | 1 | 2012 | 12 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 729 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2014 | 346 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 955 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1174 | 0.020 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2011 | 8 | 0.020 |
Why?
|
| Evoked Potentials, Visual | 1 | 2011 | 18 | 0.020 |
Why?
|
| Cerebral Hemorrhage, Traumatic | 1 | 2011 | 1 | 0.020 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2011 | 47 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2011 | 107 | 0.020 |
Why?
|
| Brain Edema | 1 | 2011 | 50 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1266 | 0.020 |
Why?
|
| Syndrome | 1 | 2011 | 255 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2012 | 291 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2011 | 106 | 0.020 |
Why?
|
| Bioprosthesis | 1 | 2011 | 101 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1753 | 0.020 |
Why?
|
| Mitral Valve | 1 | 2011 | 166 | 0.020 |
Why?
|
| Heart Valve Prosthesis | 1 | 2011 | 222 | 0.020 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2011 | 164 | 0.020 |
Why?
|
| Aortic Valve | 1 | 2011 | 249 | 0.020 |
Why?
|
| Glasgow Outcome Scale | 1 | 2008 | 15 | 0.020 |
Why?
|
| Mice | 1 | 2020 | 8474 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2011 | 328 | 0.020 |
Why?
|
| Neurofibroma | 1 | 2007 | 11 | 0.020 |
Why?
|
| Neurilemmoma | 1 | 2007 | 26 | 0.020 |
Why?
|
| Mannitol | 1 | 2006 | 25 | 0.020 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2006 | 22 | 0.020 |
Why?
|
| Resuscitation | 1 | 2006 | 77 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 1 | 2006 | 30 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2005 | 19 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2006 | 190 | 0.020 |
Why?
|
| Heart Failure | 1 | 2011 | 1180 | 0.010 |
Why?
|